Pharmaceuticals
7 articles
Biodegradable Carriers Market Soars Amidst Challenges
By 2035, the global market for biodegradable formulation carriers is projected to swell to $15.
Life Sciences Must Build A Business Case For Health Outcomes
Over 20% of all U.S. prescriptions are never filled. For high-cost therapies, this problem intensifies: 60% of prescriptions costing $500 or more out-of-pocket are abandoned, according to Healthcare I
What Are Data-Driven Biopharma Strategy Analytics Firm Partnerships?
A major pharmaceutical company recently cut its drug development timeline by 15% on a key oncology candidate, attributing the acceleration directly to a new partnership with a specialized AI analytics
Next Wave of Technologies Beyond AI Disrupting Enterprises in 2026
A major pharmaceutical company recently announced a 30% reduction in drug discovery timelines using synthetic biology platforms, a breakthrough entirely unrelated to AI.
Germany Seasonal Influenza Vaccines Market Defined by Policy and Production Cycles
Germany's seasonal influenza vaccine market is characterized by a dual-track procurement system, a time-compressed annual production cycle, and significant regulatory oversight. These elements create unique operational challenges and market dynamics.
Global Retinal Drugs Biologics Market Forecast to 2035 Shows Growth
The global retinal drugs and biologics market is projected for significant growth through 2035, primarily driven by aging populations and the increasing prevalence of diabetes. This expansion is also fueled by ongoing therapeutic innovation, including next-generation treatments for conditions like nAMD, DME, and geographic atrophy.
The Role of Small Molecule API in Pharmaceutical Innovation: A Market Analysis
Small molecule APIs are the often-overlooked foundation of modern medicine, representing a dynamic and growing force in drug development. This analysis delves into their fundamental characteristics, market trajectory, and enduring importance.